Modulators of the cx3cr1 receptor and therapeutic uses thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/02 (2006.01)

Patent

CA 2746976

The present invention concerns modulators of the CX3CR1 receptor. More specifically, antagonists and agonists of the CX3CR1 receptor have been identified. These antagonists and agonists can be used for treating an inflammatory disorder, an autoimmune disorder, a cardiovascular disease, a neurodegenerative disease, a graft versus host disease, a behavioral disorder, a cicatrisation disorder, a viral infection, cancer or pain. They may also be used as an adjuvant in a vaccine composition.

Cette invention concerne des modulateurs du récepteur CX3CR1. L'invention concerne plus spécifiquement l'identification d'antagonistes et d'agonistes du récepteur CX3CR1. Ces antagonistes et agonistes peuvent être utilisés pour traiter un état inflammatoire, une maladie auto-immune, une maladie cardiovasculaire, une maladie neurodégénérative, la réaction du greffon contre l'hôte, un trouble du comportement, un problème de cicatrisation, une infection virale, le cancer ou la douleur. Ils peuvent également être utilisés en tant qu'adjuvant dans une composition vaccinale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulators of the cx3cr1 receptor and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of the cx3cr1 receptor and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of the cx3cr1 receptor and therapeutic uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1446698

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.